Company / EPS (Diluted)
Cytosorbents Corp EPS (Diluted) History
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.46
FY2018
5-year range
-$1.29 / -$0.19
FY2014-FY2018
Trend
-21.1%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 8 years, ranging from $-1.29 in FY2016 to $-0.03 in FY2013.
Based on SEC 10-K filings.
-0.46 in FY2018.
Improved from $-1.29 to $-0.46 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2018, eps (diluted) decreased 21.1% year-over-year.
- Peak eps (diluted) was recorded in FY2013.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -4.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2018 | -$0.46 | -21.1% |
| FY2017 | -$0.38 | +70.5% |
| FY2016 | -$1.29 | -578.9% |
| FY2015 | -$0.19 | +74.7% |
| FY2014 | -$0.75 | -2400.0% |
| FY2013 | -$0.03 | +40.0% |
| FY2012 | -$0.05 | +0.0% |
| FY2011 | -$0.05 | - |
As of FY2018 · SEC 10-K · Updated Jun 24, 2026